CANNAPHARMARX, INC. Research and Development Expense
CANNAPHARMARX, INC. (CPMD) reported Research and Development Expense of $145.82 thousand for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2015-11-13
- CANNAPHARMARX, INC. research and development expense for the quarter ending 2015-09-30 was $145.82K, a 7.92% increase year-over-year.
- CANNAPHARMARX, INC. research and development expense for the quarter ending 2015-06-30 was $161.72K, a 334.72% increase year-over-year.
- CANNAPHARMARX, INC. research and development expense for the quarter ending 2015-03-31 was $160.84K.
- CANNAPHARMARX, INC. research and development expense for the quarter ending 2014-12-31 was $151.83K.
- CANNAPHARMARX, INC. research and development expense for fiscal 2014 was $324.15K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2015-09-30 | $145.82K 10-Q · filed 2015-11-13 | $307.54K derived: sum of 2 quarters · filed 2015-11-13 | $468.38K 10-Q · filed 2015-11-13 | $620.21K derived: sum of 4 quarters · filed 2015-11-13 |
| 2015-06-30 | $161.72K 10-Q · filed 2015-08-12 | $322.56K 10-Q · filed 2015-08-12 | $474.39K derived: sum of 3 quarters · filed 2015-08-12 | $609.51K derived: sum of 4 quarters · filed 2015-11-13 |
| 2015-03-31 | $160.84K 10-Q · filed 2015-05-14 | $312.67K derived: sum of 2 quarters · filed 2015-05-14 | $447.79K derived: sum of 3 quarters · filed 2015-11-13 | $484.99K derived: sum of 4 quarters · filed 2015-11-13 |
| 2014-12-31 | $151.83K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $286.95K derived: sum of 2 quarters · filed 2015-11-13 | $324.15K derived: sum of 3 quarters · filed 2015-11-13 | $324.15K 10-K · filed 2015-03-31 |
| 2014-09-30 | $135.12K 10-Q · filed 2015-11-13 | $172.32K derived: sum of 2 quarters · filed 2015-11-13 | $172.32K 10-Q · filed 2015-11-13 | |
| 2014-06-30 | $37.20K 10-Q · filed 2015-08-12 | $37.20K 10-Q · filed 2015-08-12 |